Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1997-04-15
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 5142228, 5142242, 5142265, 5142325, 5142338, 514253, 514316, 514318, 514321, 514338, 514373, 514422, 514432, 514762, 514912, 514913, 514914, A61J 105, A61K 908, A61K 31355, A61K 4734
Patent
active
056209703
ABSTRACT:
The present invention is directed to topical ophthalmic formulations of carbonic anhydrase inhibitors and polyethoxylated derivatives of castor oil. Methods for using the formulations for treating and controlling glaucoma and ocular hypertension are also disclosed.
REFERENCES:
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4829088 (1989-05-01), Doulakas
patent: 4960799 (1990-10-01), Nagy
patent: 5147647 (1992-09-01), Darougar
patent: 5153192 (1992-10-01), Dean et al.
patent: 5240923 (1993-08-01), Dean et al.
patent: 5378703 (1995-01-01), Dean et al.
Hata, Murano, and Ueda, CA 118:261059, Ophthalmic Solutions Containing Cyclosporin and Surfactants (1993).
Koide, CA 122:17250, Vitamin A-Solubilized Eye Drops (1995).
Fukahori, Uchino, and Takahashi, CA 118:109767, Aqueous Vitamin E Solutions Containing Surfactants (1993).
Fukahori, Takahashi, and Uchino, CA 114:254038, Stable Eye Drops Containing Vitamin E, FAD Sodium Salt, Allantoin, and Glycyrrhizin (1991).
Takahashi, Fukahori, Uchino, and Eino, CA 114:254039, Stable FAD Sodium Salt or Cyanocobalamine Eye Drops (1991).
Koide and Kojima, CA 120:86468, Stable Eyedrops of Naphazoline Containing Nonionic Surfactants and Glycyrrhizinate Salts (1994).
Koide, CA121:91816, Stable Solutions Containing Solubilized Vitamin A Derivatives (1994).
Koide and Aoshima, CA 121:308384, Stable Vitamin A-and E-Solubilized Eye Drops (1994).
Ali Yusuf
Dean Thomas R.
Gerson Steven H.
Han Wesley W.
Jani Rajni
Alcon Laboratories Inc.
Nutter Nathan M.
Yeager Sally
LandOfFree
Topical ophthalmic carbonic anhydrase inhibitor formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic carbonic anhydrase inhibitor formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic carbonic anhydrase inhibitor formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-360870